COMPANY SPOTLIGHT -- Bayer Schering.

The article reports that Bayer Schering made a positive performance during the first half of the year and a second quarter sale due to product lines like Yasmin and Betaferon. However, the pharmaceutical company's focus is on the new oncology treatment Nexavar. The company is engaged in developing, manufacturing and selling pharmaceutical products for gynecology, andrology and oncology markets. Bayer Schering's also offers products for multiple sclerosis.